期刊文献+

前列腺素E1促进血管内皮细胞增生和迁移及其机制 被引量:11

Promoting effects and mechanisms of prostaglandin E1 on poliferation and migration of endothelial cells
原文传递
导出
摘要 目的探讨前列腺素E1(PGE1)促进人脐静脉内皮细胞(HUVEC)增生、迁移及其机制。方法应用免疫印迹,酶联免疫吸附试验和其他细胞功能试验检测PGE1对HUVEC的作用及其机制;应用免疫印迹检测大鼠主动脉血管平滑肌细胞(VSMC)的血管内皮生长因子(VEGF)表达。结果PGE1刺激HUVEC VEGF表达、ERK和p38磷酸化;贝伐单抗中和PGE1诱导的HUVEC条件培养液内的VEGF,抑制细胞增生和迁移以及类毛细血管形成;PD98059或SB203580,均抑制PGE1诱导的HUVEC表达VEGF、HUVEC增生和迁移;此外,H89或Rp—cAMP抑制PGE1诱导的VSMC VEGF的表达。结论PGE1通过VEGF诱导内皮细胞增生、迁移和类毛细血管形成的机制为它在动脉缺血性疾病和其他相关疾病的应用进一步提供了理论支持。 Objective To investigate the mechanism(s) that prostaglandin E1 (PGE1) promotes human umbilical vein endothelial cell (HUVEC)proliferation and migration. Methods Western blot, enzyme linked immunosorbent assay, cell proliferation and cell migration tests, and tube formation were used for analyzing the roles and mechanisms of PGE1 on HUVEC ;Western blot was used for analyzing the effects of PGE1 on the expression of vascular endothelial growth factor (VEGF) in rat aortic vascular smooth muscle cells (VSMC). Results PGE1 significantly increased VEGF expression of HUVEC in time and a dose dependent manner with concomitantly increased HUVEC proliferation; treatment of HUVEC with Bevacizumab apparently suppressed PGEl-stimulated VEGF expression, which led to decreased tube formation, reduced cell proliferation and migration by 41% and 38%, respectively, compared with PGE1 treatment alone ; PGE1 time-dependently induced both phosphorylation of ERK and p38 in HUVEC, whereas ERK inhibitor, PD98059, or p38 inhibitor, SB203580, blocked PGEl-induced VEGF expression of HUVEC, resulting in dramatically suppression of HUVEC proliferation and migration compared with PGE1 treatment alone (60% and 55% by PD98059, 62% and 51% by SB203580, respectively); in addition, cAMP-dependent protein kinase A inhibitor, H89 or Rp-cAMP blocked PGEl-induced VEGF expression in VSMC. Conclusion PGE1 promotion of proliferation, migration and tube formation of HUVEC via VEGF further provides a novel theoretical support in efficacy of PGE1 treatment of critical limb ischemia and other related diseases.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第3期222-225,共4页 National Medical Journal of China
关键词 前列腺素E1 内皮细胞 血管内皮生长因子 增生 迁移 Prostaglandin El Endothelial cell Vascular endothelial growth factor Proliferation Migration
  • 相关文献

参考文献3

二级参考文献84

  • 1王爱红,许樟荣,许永杰,陈平,王玉珍,杨乐冰.前列腺素E_1脂微球载体制剂治疗糖尿病下肢动脉病变的临床观察[J].中华老年多器官疾病杂志,2005,4(1):22-25. 被引量:62
  • 2管珩,刘志民,李光伟,郭晓蕙,许樟榕,邹大进,邢惠莉,刘伟,盛正妍,田浩明,朱大龙,于德民,庄维特,陈璐璐,翁建平.50岁以上糖尿病人群周围动脉闭塞性疾病相关因素分析[J].中华医学杂志,2007,87(1):23-27. 被引量:119
  • 3American Heart Association. Heart Disease and Stroke Statistics2003 Update. Dallas. In: American Heart Association, 2003.
  • 4照日.血管内皮生长因子治疗严重冠心病安全有效[J].中华医学杂志,2001,81:36-36.
  • 5Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg, 1999, 68: 830-837.
  • 6Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ,Giordano FJ, et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation, 2003, 107 :1359-1365.
  • 7Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebocontrolled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation, 2002, 105:2012-2018.
  • 8Yoon YS, Murayama T, Gravereaux E, et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and amehorates secondary lymphedema. J Clin Invest, 2003, 111:717-725.
  • 9Kloner RA, Dow J, Chung G, et al. Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model. J Thromb Thrombolysis, 2000, 10: 285-289.
  • 10Isner JM, Vale PR, Symes JF, et al. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res,2001, 89 : 389-400.

共引文献7

同被引文献64

引证文献11

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部